BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 27050273)

  • 1. Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma.
    Jiang CF; Wen LZ; Yin C; Xu WP; Shi B; Zhang X; Xie WF
    Oncotarget; 2016 May; 7(19):27408-21. PubMed ID: 27050273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
    Yin C; Wang PQ; Xu WP; Yang Y; Zhang Q; Ning BF; Zhang PP; Zhou WP; Xie WF; Chen WS; Zhang X
    Hepatology; 2013 Dec; 58(6):1964-76. PubMed ID: 23775631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum deprivation-response protein induces apoptosis in hepatocellular carcinoma through ASK1-JNK/p38 MAPK pathways.
    Chen X; Ma W; Yao Y; Zhang Q; Li J; Wu X; Mei C; Jiang X; Chen Y; Wang G; Wang K; Liu Y; Guo Y; Liu Z; Yuan Y
    Cell Death Dis; 2021 Apr; 12(5):425. PubMed ID: 33931585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase.
    Nakagawa H; Hirata Y; Takeda K; Hayakawa Y; Sato T; Kinoshita H; Sakamoto K; Nakata W; Hikiba Y; Omata M; Yoshida H; Koike K; Ichijo H; Maeda S
    Hepatology; 2011 Jul; 54(1):185-95. PubMed ID: 21488081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
    Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
    Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice.
    Zeng X; Lin Y; Yin C; Zhang X; Ning BF; Zhang Q; Zhang JP; Qiu L; Qin XR; Chen YX; Xie WF
    Hepatology; 2011 Dec; 54(6):2036-47. PubMed ID: 21898499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
    Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
    Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression.
    Ning BF; Ding J; Liu J; Yin C; Xu WP; Cong WM; Zhang Q; Chen F; Han T; Deng X; Wang PQ; Jiang CF; Zhang JP; Zhang X; Wang HY; Xie WF
    Hepatology; 2014 Nov; 60(5):1607-19. PubMed ID: 24752868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR7 correlates with the differentiation of hepatocellular carcinoma and suppresses HNF4α expression through the ERK pathway.
    Xue TC; Jia QA; Bu Y; Chen RX; Cui JF; Tang ZY; Ye SL
    Oncol Rep; 2014 Dec; 32(6):2387-96. PubMed ID: 25242412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gα12 overexpressed in hepatocellular carcinoma reduces microRNA-122 expression via HNF4α inactivation, which causes c-Met induction.
    Yang YM; Lee CG; Koo JH; Kim TH; Lee JM; An J; Kim KM; Kim SG
    Oncotarget; 2015 Aug; 6(22):19055-69. PubMed ID: 25965999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
    Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
    Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
    Yin C; Lin Y; Zhang X; Chen YX; Zeng X; Yue HY; Hou JL; Deng X; Zhang JP; Han ZG; Xie WF
    Hepatology; 2008 Nov; 48(5):1528-39. PubMed ID: 18925631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of Hepatocyte Nuclear Factor 4 α by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation.
    Park S; Ha YN; Dezhbord M; Lee AR; Park ES; Park YK; Won J; Kim NY; Choo SY; Shin JJ; Ahn CH; Kim KH
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice.
    Cai WY; Lin LY; Hao H; Zhang SM; Ma F; Hong XX; Zhang H; Liu QF; Ye GD; Sun GB; Liu YJ; Li SN; Xie YY; Cai JC; Li BA
    Hepatology; 2017 Apr; 65(4):1206-1221. PubMed ID: 27809333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.
    Maeda Y; Hwang-Verslues WW; Wei G; Fukazawa T; Durbin ML; Owen LB; Liu X; Sladek FM
    Biochem J; 2006 Dec; 400(2):303-13. PubMed ID: 16895524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.
    Yao D; Peng S; Dai C
    BMC Cancer; 2013 Sep; 13():432. PubMed ID: 24059685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
    Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy.
    Cozzolino AM; Alonzi T; Santangelo L; Mancone C; Conti B; Steindler C; Musone M; Cicchini C; Tripodi M; Marchetti A
    J Hepatol; 2013 Jan; 58(1):65-72. PubMed ID: 22960426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT-enhancer binding protein-α (C/EBPα) and hepatocyte nuclear factor 4α (HNF4α) regulate expression of the human fructose-1,6-bisphosphatase 1 (FBP1) gene in human hepatocellular carcinoma HepG2 cells.
    Wattanavanitchakorn S; Rojvirat P; Chavalit T; MacDonald MJ; Jitrapakdee S
    PLoS One; 2018; 13(3):e0194252. PubMed ID: 29566023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.